Page last updated: 2024-12-06
triuret
Description
Triuret is a white, crystalline organic compound with the formula (NH2CONH)2CO. It is a cyclic trimer of urea, and it can be synthesized by heating urea in the presence of a strong acid. Triuret is a relatively rare compound, and its properties and uses have not been extensively studied. However, it is known to be a weak acid and a good hydrogen-bond donor. Triuret has been investigated for its potential use in fertilizer and in the production of polymers. It has also been explored as a potential starting material for the synthesis of other nitrogen-containing compounds. Studies on triuret are ongoing to explore its potential in various applications, including its use in biomedicine and materials science.'
triuret: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 68400 |
| CHEBI ID | 36955 |
| SCHEMBL ID | 653996 |
| MeSH ID | M0068805 |
Synonyms (39)
| Synonym |
|---|
| nsc 29081 |
| urea, n,n''-carbonylbis- |
| unii-6id4233c3s |
| 6id4233c3s , |
| einecs 209-147-7 |
| urea, n,n'-bis(aminocarbonyl)- |
| triuret |
| urea,n''-carbonylbis- |
| 556-99-0 |
| diimidotricarbonic diamide |
| dicarbamylurea |
| urea,n'-bis(aminocarbonyl)- |
| carbonyldiurea |
| nsc29081 |
| nsc-29081 |
| CHEBI:36955 |
| n,n'-bis(aminocarbonyl)urea |
| 2,4-diimidotricarbonic diamide |
| tricarbonodiimidic diamide |
| 1,3-dicarbamylurea |
| 1,3-dicarbamoylurea |
| AKOS006340624 |
| [(carbamoylamino)carbonyl]urea |
| SCHEMBL653996 |
| triuret [usp-rs] |
| triuret [mi] |
| DTXSID9060314 |
| WNVQBUHCOYRLPA-UHFFFAOYSA-N |
| tricarbonodiimidic diamide # |
| (n h2) (c o) (n h) (c o) (n h) (c o) (n h2) |
| thiuret |
| Q1569711 |
| AMY16437 |
| D97221 |
| TIU , |
| (carbonylbis(azanediyl))bis(aminomethanone) |
| EN300-153744 |
| AS-77942 |
| Z1203578071 |
Drug Classes (1)
| Class | Description |
|---|
| condensed ureas | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 26.54
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 26.54 (24.57) | | Research Supply Index | 2.20 (2.92) | | Research Growth Index | 4.06 (4.65) | | Search Engine Demand Index | 29.35 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |